Alison P. P McGuigan

Prof. Alison P. P McGuigan

University of Toronto
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Immunity
Verified
Journal Article
Closed access
KHKebria Hezaveh
Kebria Hezaveh
RSRahul S. Shinde
Rahul S. Shinde
AKAndreas Klötgen
Andreas Klötgen
MHMarie Jo Halaby
Marie Jo Halaby
SLSara Lamorte
Sara Lamorte
TMTracy L. McGaha
Tracy L. McGaha

18 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPElisabeth Prince
Elisabeth Prince
JCJennifer Cruickshank
Jennifer Cruickshank
WBWail Ba-Alawi
Wail Ba-Alawi
KHKelsey Hodgson
Kelsey Hodgson
JHJillian Haight
Jillian Haight
EKEugenia Kumacheva
Eugenia Kumacheva
Patient-derived tumor organoids (PDOs) are a highly promising preclinical model that recapitulates the histology, gene expression, and drug response of the donor patient tumor. Currently, PDO culture relies on basement-membrane extract (BME), which suffers from batch-to-batch variability, the presence of xenogeneic compounds and residual growth factors, and poor control of mechanical properties. Additionally, for the development of new organoid lines from patient-derived xenografts, contamination of murine host cells poses a problem. We propose a nanofibrillar hydrogel (EKGel) for the initiation and growth of breast cancer PDOs. PDOs grown in EKGel have histopathologic features, gene expression, and drug response that are similar to those of their parental tumors and PDOs in BME. In addition, EKGel offers reduced batch-to-batch variability, a range of mechanical properties, and suppressed contamination from murine cells. These results show that EKGel is an improved alternative to BME matrices for the initiation, growth, and maintenance of breast cancer PDOs.

23 November 2015 in Nature Materials
Verified
Journal Article
Open access
PDF file
DRDarren Rodenhizer
Darren Rodenhizer
EGEdoardo Gaude
Edoardo Gaude
DCDan Cojocari
Dan Cojocari
RMRadhakrishnan Mahadevan
Radhakrishnan Mahadevan
CFChristian Frezza
Christian Frezza
AMAlison P. P McGuigan
Alison P. P McGuigan
The profound metabolic reprogramming that occurs in cancer cells has been investigated primarily in two-dimensional cell cultures, which fail to recapitulate spatial aspects of cell-to-cell interactions as well as tissue gradients present in three-dimensional tumours. Here, we describe an engineered model to assemble three-dimensional tumours by rolling a scaffold–tumour composite strip. By unrolling the strip, the model can be rapidly disassembled for snapshot analysis, allowing spatial mapping of cell metabolism in concert with cell phenotype. We also show that the establishment of oxygen gradients within samples that are shaped by oxygen-dependent signalling pathways, as well as the consequential variations in cell growth, response to hypoxic gradients extending from normoxia to severe hypoxia, and therapy responsiveness, are consistent with those of tumours in vivo. Moreover, by using liquid chromatography tandem mass spectrometry, we mapped cellular metabolism and identified spatially defined metabolic signatures of cancer cells to reveal both known and novel metabolic responses to hypoxia.

29 January 2020 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
EDElisa D’aRcangelo
Elisa D’aRcangelo
NWNila C. Wu
Nila C. Wu
JCJose L. Cadavid
Jose L. Cadavid
AMAlison P. P McGuigan
Alison P. P McGuigan
The tumour microenvironment (TME) determines vital aspects of tumour development, such as tumour growth, metastases and response to therapy. Cancer-associated fibroblasts (CAFs) are abundant and extremely influential in this process and interact with cellular and matrix TME constituents such as endothelial and immune cells and collagens, fibronectin and elastin, respectively. However, CAFs are also the recipients of signals—both chemical and physical—that are generated by the TME, and their phenotype effectively evolves alongside the tumour mass during tumour progression. Amid a rising clinical interest in CAFs as a crucial force for disease progression, this review aims to contextualise the CAF phenotype using the chronological framework of the CAF life cycle within the evolving tumour stroma, ranging from quiescent fibroblasts to highly proliferative and secretory CAFs. The emergence, properties and clinical implications of CAF activation are discussed, as well as research strategies used to characterise CAFs and current clinical efforts to alter CAF function as a therapeutic strategy.

21 January 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CLCamila Londono
Camila Londono
MLM. Jimena Loureiro
M. Jimena Loureiro
BSBenjamin Slater
Benjamin Slater
PLPetra B. Lücker
Petra B. Lücker
JSJohn Soleas
John Soleas
AMAlison P. P McGuigan
Alison P. P McGuigan
Significance: Group cell migration in response to guidance signals is a critical process in determining tissue organization. Here we explore the response of groups of cells to topographic guidance signals and reveal that guidance information can be transmitted between cells within the group. Significantly, we show that guidance information transmission is not dependent on cell–cell junctions or tensional forces within cells. Instead, we propose that signal transmission arises from a volume exclusion-type mechanism and is an emergent property that can arise in dense cell populations.

19 January 2018 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
DRDarren Rodenhizer
Darren Rodenhizer
TDTeresa Dean
Teresa Dean
EDElisa D'ARcangelo
Elisa D'ARcangelo
AMAlison P. P McGuigan
Alison P. P McGuigan